Report overview
Antihormonal Cancer Therapy is a treatment with drugs, surgery, or radiation in order to block the production or action of a hormone. Antihormone therapy may be used in cancer treatment because certain hormones are able to stimulate the growth of some types of tumors.
This report contains market size and forecasts of Antihormonal Cancer Therapies in Global, including the following market information:
Global Antihormonal Cancer Therapies Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Antihormonal Cancer Therapies market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Radiations Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Antihormonal Cancer Therapies include AstraZeneca, Novartis, Pfizer, Sanofi, Takeda, Roche, Amgen, Samyang Biopharmaceuticals and Tolmar, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Antihormonal Cancer Therapies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antihormonal Cancer Therapies Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Antihormonal Cancer Therapies Market Segment Percentages, by Type, 2021 (%)
Radiations
Drugs
Surgeries
Others
Global Antihormonal Cancer Therapies Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Antihormonal Cancer Therapies Market Segment Percentages, by Application, 2021 (%)
Breast Cancer
Prostate Cancer
Other
Global Antihormonal Cancer Therapies Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Antihormonal Cancer Therapies Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antihormonal Cancer Therapies revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Antihormonal Cancer Therapies revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Novartis
Pfizer
Sanofi
Takeda
Roche
Amgen
Samyang Biopharmaceuticals
Tolmar
Bluebird Bio
Bristol-Myers Squibb
Exelixis
Guardant Health
Illumina
